Literature DB >> 23543592

Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators.

Moniek W M van de Luijtgaarden1, Kitty J Jager, Vianda S Stel, Anneke Kramer, Ana Cusumano, Robert F Elliott, Claudia Geue, Alison M MacLeod, Benedicte Stengel, Adrian Covic, Fergus J Caskey.   

Abstract

BACKGROUND: An increase in the dialysis programme expenditure is expected in most countries given the continued rise in the number of people with end-stage renal disease (ESRD) globally. Since chronic peritoneal dialysis (PD) therapy is relatively less expensive compared with haemodialysis (HD) and because there is no survival difference between PD and HD, identifying factors associated with PD use is important.
METHODS: Incidence counts for the years 2003-05 were available from 36 countries worldwide. We studied associations of population characteristics, macroeconomic factors and renal service indicators with the percentage of patients on PD at Day 91 after starting dialysis. With linear regression models, we obtained relative risks (RRs) with 95% confidence intervals (CIs).
RESULTS: The median percentage of incident patients on PD was 12% (interquartile range: 7-26%). Determinants independently associated with lower percentages of patients on PD were as follows: patients with diabetic kidney disease (per 5% increase) (RR 0.93; 95% CI 0.89-0.97), health expenditure as % gross domestic product (per 1% increase) (RR 0.93; 95% CI 0.87-0.98), private-for-profit share of HD facilities (per 1% increase) (RR 0.996; 95% CI 0.99-1.00; P = 0.04), costs of PD consumables relative to staffing (per 0.1 increase) (RR 0.97; 95% CI 0.95-0.99).
CONCLUSIONS: The factors associated with a lower percentage of patients on PD include higher diabetes prevalence, higher healthcare expenditures, larger share of private-for-profit centres and higher costs of PD consumables relative to staffing. Whether dialysis modality mix can be influenced by changing healthcare organization and funding requires additional studies.

Entities:  

Keywords:  dialysis; epidemiology; health policy; macroeconomics

Mesh:

Year:  2013        PMID: 23543592     DOI: 10.1093/ndt/gft053

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: the Romanian Renal Registry.

Authors:  Gabriel Mircescu; Gabriel Stefan; Liliana Gârneaţă; Irina Mititiuc; Dimitrie Siriopol; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-10-27       Impact factor: 2.370

Review 2.  Peritoneal Dialysis in Western Countries.

Authors:  Dirk G Struijk
Journal:  Kidney Dis (Basel)       Date:  2015-09-03

Review 3.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

4.  Determination of the optimal case definition for the diagnosis of end-stage renal disease from administrative claims data in Manitoba, Canada.

Authors:  Paul Komenda; Nancy Yu; Stella Leung; Keevin Bernstein; James Blanchard; Manish Sood; Claudio Rigatto; Navdeep Tangri
Journal:  CMAJ Open       Date:  2015-07-17

5.  Chronic kidney disease in low- and middle-income countries.

Authors:  John W Stanifer; Anthony Muiru; Tazeen H Jafar; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2016-02-04       Impact factor: 5.992

6.  Fifty years of ERA-EDTA Registry-a registry in transition.

Authors:  Kitty J Jager; Christoph Wanner
Journal:  Kidney Int Suppl (2011)       Date:  2015-06

7.  Dialysis practice from the English NHS to the orient.

Authors:  Pearl Pai; Tak Mao Chan
Journal:  Clin Kidney J       Date:  2013-09-07

8.  Perception about transplant of rural and urban patients with chronic kidney disease; a qualitative study.

Authors:  Nasrollah Ghahramani; Chloe Wang; Ali Sanati-Mehrizy; Ankita Tandon
Journal:  Nephrourol Mon       Date:  2014-03-02

9.  Impact of initial dialysis modality on mortality: a propensity-matched study.

Authors:  Bård Waldum-Grevbo; Torbjørn Leivestad; Anna V Reisæter; Ingrid Os
Journal:  BMC Nephrol       Date:  2015-10-30       Impact factor: 2.388

10.  A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.

Authors:  Svenja K Bahte; Marcus Hiss; Ralf Lichtinghagen; Jan T Kielstein
Journal:  BMC Nephrol       Date:  2014-04-16       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.